Repeat biopsy in relapsed or refractory diffuse large B cell lymphoma: a nationwide survey and retrospective study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Repeat biopsy in relapsed or refractory diffuse large B cell lymphoma: a nationwide survey and retrospective study

Published:2022-05-28 Issue:10 Volume:63 Page:2461-2468
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Berger Tamar¹²^ORCID,Geiger Karyn Revital¹²,Yeshurun Moshe¹²,Gafter‑Gvili Anat¹²³,Shochat Tzippy⁴,Gurion Ronit¹²,Raanani Pia¹²,Pasvolsky Oren¹²^ORCID

Affiliation:

1. Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center, Petah-Tikva, Israel

2. Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel

3. Department of Medicine A, Rabin Medical Center, Petah-Tikva, Israel

4. Bio-Statistical Unit, Rabin Medical Center, Petah Tikva, Israel

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2022.2081325

Reference18 articles.

1. Diffuse large B‐cell lymphoma: 2019 update on diagnosis, risk stratification, and treatment

2. 2021 Update on Diffuse large B cell lymphoma: A review of current data and potential applications on risk stratification and management

3. Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification

4. Management of relapsed/refractory DLBCL

5. Guidelines for the management of diffuse large B-cell lymphoma

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP